← Back to all articles

Articles · Earnings, Guidance Tracker

The Hartford (HIG) Q3 2026 Earnings: Revenue, EPS and Outlook

Q3 2026 (quarter ended Sep 30, 2026): revenue, EPS and full-year guidance from the SEC filing

Published Nov 5, 2026

TL;DR

  • The Hartford: no outlook given; revenue +3.9% vs a year earlier.

The Hartford's results for Q3 2026 (quarter ended Sep 30, 2026) come from the company's own earnings release, filed with the SEC on 2026-10-26. Everything below is taken from that filing; quotes are copied exactly. Company outlooks are the company's own.

At a glance

ItemValue
Revenue (GAAP)$7,220 million (+3.9% vs a year earlier)
Diluted EPS (GAAP)$4.82
Adjusted per-share figure (company's non-GAAP measure; FFO/AFFO for REITs)$3.50
Full-year guidanceNo outlook given

Guidance

No financial outlook in the release.

Why this label: No outlook section or full-year figures in the release or supplement; only rating-agency 'stable outlook' text.

From the release

Revenue: "Total revenues · $ · 7,220 · $ · 7,263 · $ · 6,941 · $ · 7,047 · $ · 6,946"

Earnings per share: "Third quarter 2026 net income available to common stockholders of $1.3 billion ($4.82 per diluted share) increased 23% from $1.1 billion ($3.77 per diluted share) over the same period in 2025. Core earnings* of $956 million ($3.50 core earnings per diluted share*)"

Quotes are copied from the filing; in table rows, cell borders are shown as “·”.

Key fact: Raised quarterly common dividend 12% to $0.67; Q3 EPS $4.82

Source

The Hartford earnings release (SEC filing), accession 0000874766-26-000079, filed 2026-10-26.

Part of the Q3 2026 Guidance Tracker. Educational only, not advice. Free weekly recap every Sunday: yieldterminalpro.com/newsletter.

Get the Sunday Recap by email

One email a week. Every issue is published on the site too, so this is only about getting it in your inbox.

Subscribing signs you up for the free YieldTerminal Sunday recap, one email a week. Educational only, not financial advice. Unsubscribe any time.

Educational commentary, not a recommendation to buy or sell anything.